Litigation Details for Bayer Healthcare LLC v. Aurobindo Pharma Ltd. (D. Del. 2021)

Bayer Healthcare LLC v. Aurobindo Pharma Ltd. (D. Del. 2021)

Docket		Date Filed	2021-11-05
Court	District Court, D. Delaware	Date Terminated	2022-10-24
Cause	35:1 Patent Infringement	Assigned To	William C. Bryson
Jury Demand	None	Referred To
Patents	8,071,073; 8,518,919; 9,919,050
Link to Docket	External link to docket

Details for Bayer Healthcare LLC v. Aurobindo Pharma Ltd. (D. Del. 2021)

Date Filed	Document No.	Description	Snippet	Link To Document
2021-11-04	1	Complaint	of U.S. Patent No. 8,071,073 (“the ’073 patent”); U.S. Patent No. 8,518,919 (“the ’919 patent”); and …and U.S. Patent No. 9,919,050 (“the ’050 patent”). These patents are referred to collectively herein as… the ’073 patent, including at least claims 2 and 3 of the ’073 patent, and the ’073 patent has been … by the ’919 patent, including at least claim 1 of the ’919 patent, and the ’919 patent has been listed… by the ’050 patent, including at least claim 1 of the ’050 patent, and the ’050 patent has been listed	External link to document
2021-11-04	3	ANDA Form	Date of Expiration of Patent: Patent No. 8,071,073 expires on June 4, 2028 and Patent Nos. 8,518,919 and … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2021 24 October 2022 1:21-cv-01575 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-11-04	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,071,073 B2 ;8,518,919 B2 ;9,919,050…2021 24 October 2022 1:21-cv-01575 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document